Excess deaths 2025
Dr. John Campbell | May 28, 2025
Excess mortality: Deaths from all causes compared to average over previous years
https://bmjpublichealth.bmj.com/content/2/1/e000282
1 January 2020 until 31 December 2022
47 countries of the Western World, 3, 098, 456
Excess mortality
2021, 42 countries
2022, 43 countries
Conclusions
Excess mortality has remained high in the Western World for three consecutive years
This raises serious concerns.
Government leaders and policymakers need to thoroughly investigate underlying causes of persistent excess mortality.
2015–2019 compared to 2020–2024
Percentage difference between the reported weekly or monthly deaths in 2020–2024 and the average deaths in the same period in 2015–2019
https://ourworldindata.org/grapher/excess-mortality-p-scores-average-baseline
Correlation and causality
Smoking is correlated with lung cancer
Asbestos exposure is correlated with mesothelioma
Alcohol consumption is associated with liver cirrhosis
Obesity is correlated with high sugar intake
Radiation exposure is correlated with cancer
Dioxin exposure is correlated with cancer
Causality may be adjudicated by larger scale associations, consistent between countries, where other explanations are unlikely, where effect follows cause, where greater exposure causes more harm with a plausible biological mechanism with coherence between bench science and epidemiological data supported by (even limited) experimentation. By analogy to other causes of harm and sometimes by reversibility.
US makes sweeping changes to key vaccine group
RT | June 10, 2025
The US Department of Health and Human Services (HHS) has dismissed all the members of a key advisory panel that has helped shape national vaccination policy for decades. Health Secretary Robert F. Kennedy Jr. said on Monday that the move was necessary to reestablish public trust and address longstanding concerns over conflicts of interest.
The Advisory Committee on Immunization Practices (ACIP) was created within the Centers for Disease Control and Prevention (CDC) in the mid-1960s. In an op-ed published on Monday in the Wall Street Journal, Kennedy claimed that the panel has “a history of conflicts of interest, persecution of dissidents, a lack of curiosity, and skewed science.”
The secretary cited reports from a House committee in 2000 and the HHS inspector general in 2009 that detailed financial connections between ACIP members and pharmaceutical companies. He said his decision to replace all 17 current members was driven by the need for a “clean slate.”
“The problem isn’t necessarily that ACIP members are corrupt. Most likely aim to serve the public interest as they understand it,” Kennedy wrote. “The problem is their immersion in a system of industry-aligned incentives and paradigms that enforce a narrow pro-industry orthodoxy.”
ACIP members are appointed to four-year terms, and eight of the most recent appointments were made in the final days of the administration of Joe Biden.
”It was very intentional,” a former senior HHS official told STAT News. “It was our goal to fill every vacancy on every [federal advisory committee] the department has, with particular focus on ones like ACIP where maintenance of our scientific expertise was critical.”
Mandy Cohen, who served as the CDC director under Biden, told NBC News the move “spreads confusion and casts doubt on transparent public health processes that protect Americans.” Richard Besser, who was acting CDC director under Barack Obama, said it “should erase any remaining doubt that he intends to impose his personal anti-vaccine agenda on the American people.”
Kennedy has long criticized aspects of US vaccine programs, arguing they are too closely aligned with industry interests and fail to prioritize public health. His detractors frequently label him an “anti-vaxxer.”
During his confirmation hearings, Kennedy pledged that his decisions would be science-driven. In his WSJ piece, he warned against attributing the American public’s “crisis of trust” solely to “misinformation or anti-science attitudes.”
APPROVE NOW, STUDY LATER: IS THIS SAFE?
The HighWire with Del Bigtree | June 5, 2025
As alarming new data reveals a spike in sudden heart attacks and strokes, the FDA has greenlit Moderna’s latest mRNA COVID shot—no placebo trials, no independent long-term safety data, and post-market studies delayed until 2029 and 2034. Once again, speed trumps caution. Is safety giving way to speed again, or are post-marketing placebo trials a step in the right direction?
Australia quietly pivots on Covid-19 vaccine policy
By Maryanne Demasi, PhD | June 3, 2025
It didn’t come with a press conference or a media blitz. In fact, there was no announcement at all.
But sometime around 2 May 2025, the Australian Department of Health quietly removed its recommendation for Covid-19 vaccination in healthy children and adolescents under 18.

The change was tucked into an online update to the Australian Immunisation Handbook—no headline, no ministerial statement, no media campaign to inform the public.
For the first time since the rollout began, Australian health authorities now say that unless a child has underlying medical conditions, they do not need the vaccine.
Australia now joins a growing list of countries backing away from the blanket approach to vaccinating low-risk populations.
In the US, health officials under HHS Secretary Robert F. Kennedy Jr. recently removed routine recommendations for Covid-19 vaccination in healthy children and pregnant women.
The CDC now leaves it up to “shared decision-making”—a tacit acknowledgment that the previous universal approach may have overreached.
Denmark, meanwhile, was ahead of the curve.
It stopped recommending the vaccine for healthy children back in 2022, citing data showing that severe Covid in children was exceedingly rare and that the benefits of mass vaccination did not outweigh the harms.
Australia’s policy reversal might be late, but what makes it striking is how quietly it was done—and how much it implicitly concedes.
For years, anyone who questioned the need to vaccinate healthy children was dismissed as anti-science or dangerous. Now, the same authorities who widely promoted the shots are quietly walking it back.
And the adverse events that critics raised early on—myocarditis, pericarditis, and other post-vaccine complications—are no longer fringe concerns. They’re acknowledged in official risk assessments.
The shift also comes at a time when the legal and regulatory framework that enabled the rapid approval of mRNA vaccines is under growing scrutiny.
In Australia, a case brought by Dr Julian Fidge, a general practitioner and former pharmacist, challenged the legality of the vaccine approvals.
He argued that Pfizer and Moderna’s mRNA vaccines should have been classified as “genetically modified organisms” under the Gene Technology Act 2000, and therefore required a licence from the Office of the Gene Technology Regulator (OGTR) before being rolled out.
But the court dismissed the case on procedural grounds, ruling that Dr Fidge lacked standing to pursue it.
Still, the case drew attention to whether these products were channelled through the wrong regulatory pathway.
That question is now at the centre of a citizen petition in the US, filed with the FDA in January 2025, claiming the agency “wrongfully and illegally” approved the mRNA Covid-19 vaccines by treating them as conventional biologics, not gene therapies.
According to the FDA’s own definition, gene therapy products are those that use genetic material to alter cellular function for therapeutic use.
By that logic, mRNA vaccines clearly qualify – and should have faced far more rigorous safety testing, including environmental risk assessments and long-term follow-up studies.
As of June, the FDA has not responded to the petition—but the implications are enormous.
If regulators in Australia or the US misclassified these products during the emergency rush, it would expose a systemic failure to apply the appropriate safeguards to an entirely new class of biotechnology.
And it’s not just about legal definitions. The public mood is shifting.
The notion that healthy children and adolescents should have been part of a sweeping global experiment with novel gene-based technologies now looks reckless in hindsight. For the public, trust has been damaged—perhaps irreparably.
That shift in perception has consequences far beyond Covid.
Billions of dollars have been invested in mRNA platforms for other diseases—flu, RSV, and cancer. So what happens if confidence in the technology craters?
Already, the US FDA has announced it will require new randomised clinical trials for annual Covid-19 boosters in “healthy” people under 65—setting a higher threshold for evidence (than immunobridging data) that may make future approvals more challenging.
The industry might dismiss this as just a hiccup—but the truth is, mRNA vaccines were never subjected to the kind of long-term scrutiny typically required of products given to healthy people, especially children.
The argument that urgency justified shortcuts has worn thin.
The real emergency now is institutional—one of captured regulators, collapsing public trust, and a health system so entangled with the pharmaceutical industry it can no longer tell the difference between evidence and marketing.
Is the FDA a mutinous ship?
By Dr Clare Craig | Health Advisory & Recovery Team | June 3, 2025
They promised change. They promised transparency. They promised reform. But with the FDA’s latest approval of Moderna’s mNEXSPIKE® covid jab, it is clear the only thing that has changed is the branding.
This so-called “reformed” FDA has just authorised a new mRNA vaccine — without testing it against a placebo. Instead, the comparator was Moderna’s previous product, already associated with a range of known adverse effects.
And yet, somehow, we’re meant to believe this is progress.
Meanwhile, the leaders heading up MAHA, elected on a promise to end the regulatory theatre and restore public trust, appear to be captaining a vessel still drifting in the same dangerous waters. They are on a mutinous ship and are wrestling for the wheel.
While the FDA continues to greenlight successive iterations of mRNA vaccines, other major Western nations long since reduced their ambitions:
- In the United Kingdom, the Joint Committee on Vaccination and Immunisation (JCVI) now recommends boosters only for individuals aged 75 and over, residents of care homes, and those with specific clinical vulnerabilities.
- France and Germany have similarly curtailed their booster programmes, focusing on high-risk populations and refraining from broad recommendations for younger, healthier demographics.
This more cautious approach is not justifiable either given the failure of these product and their safety profile. The “benefit” only ever was – and continues to be – a statistical illusion. No one should be being exposed to this unnecessary risk.
This divergence raises a critical question: How can the same body of evidence lead to such different public health policies?
Latest Inadequate Trials
The Phase 3 trial underpinning mNEXSPIKE’s approval enrolled approximately 11,400 participants aged 12 and older. While this number might seem substantial, it’s important to note that only about half received the mNEXSPIKE vaccine, while the remainder received an earlier Moderna product as a comparator. There was no placebo comparison.
This sample size is insufficient to detect rare but serious adverse events – even with a placebo. Without one you can only see differences between two sets of harm.
For context, previous studies have indicated that mRNA vaccines may be associated with an excess risk of serious adverse events of special interest, estimated at approximately 15.1 per 10,000 vaccinated individuals. This is totally unacceptable for general use even in a product that has significant benefits.
Despite approval, critical safety studies are still pending. One study, assessing safety in pregnant women, is not due until 2032. Another, evaluating vaccine effectiveness for adults aged 50–64, is still in the planning stages.
Are the FDA still pretending there is an emergency to justify these rushed decisions?
A Hollow Reformation
The USA public deserves better from their officials. They are paying for this reckless approach. The question is, can those with a more precautionary, less ideological approach, wrestle the wheel of the ship and steer her to safety?
Covid-19 vaccine reform is moving slower than many had hoped
Moderna’s latest mRNA vaccine approval stuns reform advocates—but real change demands persistence when science runs up against powerful interests
By Maryanne Demasi, PhD | June 1, 2025
Just three weeks after Dr Vinay Prasad assumed oversight of vaccines at the FDA, Moderna’s latest Covid-19 vaccine, mNEXSPIKE®, received full approval.
For those who had hoped the mRNA platform would be shelved, the decision landed like a gut punch.
Approved on 31 May 2025, the next-generation shot is intended for adults over 65, as well as individuals aged 12 to 64 with at least one risk factor for severe illness.
And it came under the watch of a man who had spent years demanding greater scientific rigour from the agency.
Prasad had been among the FDA’s most outspoken critics during the pandemic, repeatedly condemning its reliance on surrogate endpoints—such as antibody levels—rather than hard clinical outcomes like reduced hospitalisation or death.
And he didn’t just say it once. He drove the point home, over and over.
“Showing boosters improve neutralizing antibodies or other laboratory measures is not what we need,” he posted on X in July 2022. “We need randomized control trials powered for clinical endpoints showing boosters improve outcomes that people care about.”
In January 2023, he co-signed a formal Citizen Petition to the FDA stating, “This immunobridging surrogate endpoint has not been validated to predict clinical efficacy.”
Then in March 2023, he made his position even clearer on Substack. “I don’t care about transient antibody titer levels,” he wrote.
But mNEXSPIKE® appears to have been approved primarily using exactly those kinds of data—measures of immune response, not measures of meaningful outcomes.
So how do we square that?
Technically, the approval aligns with the policy Prasad outlined in a recent New England Journal of Medicine article.
There, he proposed a two-track system — no further vaccine approvals for healthy adults without RCTs showing clinical benefit—but for older adults and at-risk individuals, immunobridging data could still be acceptable.
So yes, by that standard, mNEXSPIKE® fits the rules.
But it doesn’t erase the discomfort. Because for years, Prasad insisted those very shortcuts—approving Covid vaccines based on antibody levels instead of clinical outcomes—were scientifically flimsy.
Now, under his watch, those same shortcuts are back in play.
When Robert F. Kennedy Jr. was appointed HHS Secretary, reform didn’t just seem likely—it felt imminent.
Many expected the mRNA shots would be pulled from the market, or at the very least, that new approvals would be frozen until stronger evidence emerged.
Instead, we’ve seen a flood of high-production videos and polished slogans about “restoring public trust.”
To many observers, it looks like transparency on the surface—but business as usual underneath.
Of course, no one said this would be easy.
Having worked in government as a political adviser, I know how hard it is to shift systems that are not only slow and bureaucratic, but deeply enmeshed with commercial interests. And no sector is more heavily invested in mRNA than biotech.
This isn’t just about Covid anymore. The pharmaceutical industry has poured billions into mRNA vaccines for RSV, flu, HIV, cancer, and more. Entire product pipelines are now staked on the assumption that the technology is here to stay.
Pulling the plug wouldn’t just alter public health policy—it would tank portfolios, gut R&D budgets, and unleash a political and financial firestorm from some of the most powerful corporate interests on earth.
That’s the kind of pressure Prasad is under now. That’s the reality Kennedy’s team has stepped into.
This is no longer science versus ideology. It’s science versus entrenched industry power.
And many are beginning to worry we’re watching the same playbook unfold—just with better branding.
That’s not what MAHA supporters or vaccine-injured families were hoping for. They’re not asking for tweaks. They want the shots gone. Not revised. Not updated—just gone.
But political reality rarely keeps pace with public demand. Even the most determined reformers can’t move faster than the machinery they’re trying to dismantle.
So where does that leave us?
Facing the hardest task of all—staying in the fight.
Progress may feel glacial, but it is underway.
The CDC has removed routine Covid-19 vaccine recommendations for healthy children and pregnant women. Prasad’s new framework has halted low-risk approvals unless backed by RCTs.
Yes, the mRNA platform is still alive—and still fiercely protected—but reform was never going to be easy. And it was never going to come all at once.
COVID Doubts Made You a ‘Violent Extremist’
By Jim Bovard | The Libertarian Institute | June 2, 2025
Biden administration policymakers hated you more than you knew.
Four years ago, I warned at the Libertarian Institute:
“Libertarians are in the federal crosshairs… Many libertarians assume they have nothing to fear because they are not engaged in seeking to violently overthrow the government. But the feds will be able to find many other pretexts to target peaceful citizens with supposedly subversive ideas.”
Three years ago, I warned at the Institute that White House Press Secretary Karine Jean-Pierre was damning anyone who did not kowtow to the regime:
“’When you are not with what majority of Americans are, then you know, that is extreme. That is an extreme way of thinking.’ That wacko definition of extremism designed to vilify anyone who doubts Biden will save America’s soul.”
In October 2023, I warned at the Institute:
“Federal bureaucrats heaved together a bunch of letters to contrive an ominous new acronym for the latest peril to domestic tranquility. The result: AGAAVE—’anti-government, anti-authority violent extremism’—which looks like a typo for a sugar substitute. The FBI vastly expanded the supposed AGAAVE peril by broadening suspicion from ‘furtherance of ideological agendas’ to ‘furtherance of political and/or social agendas.’ Anyone who has an agenda different from Team Biden’s could be AGAAVE’d for his own good.”
Director of National Intelligence Tulsi Gabbard recently declassified a December 13, 2021 report by the National Counterterrorism Center. Gabbard’s version had a more honest title than the original version: “Declassified Biden Administration Documents Labeling COVID Dissenters, Others as ‘Domestic Violent Extremists.’”
President Joe Biden’s Brain Trust sounded the alarm on criticisms such as “COVID-19 vaccines are unsafe, especially for children, are part of a government or global conspiracy to deprive individuals of their civil liberties and livelihoods, or are designed to start a new social or political order.” After government lockdowns had destroyed millions of jobs, only the paranoid would fear the government would ever violate their liberties or subvert their livelihoods.
Biden policymakers pretended that the surge in criticism of COVID policies was proof of the psychopathology of Biden’s opponents. But in September 2021, Biden dictated that one-hundred million Americans working for private companies must get the COVID vaccine. The official counterterrorism report stated that it anticipated that “the threat will continue at least into the winter, as many of the new COVID-19 mandates in the U.S….are implemented, including U.S. workplace vaccination policies that carry disciplinary or termination penalties.” The Supreme Court struck down most of that vaccine mandate as illegal in January 2022 but not before it had profoundly disrupted legions of lives and businesses—as well as American health care.
The other factor spurring the surge in COVID criticism was the failure of the COVID vaccines. In early 2022, the effectiveness of the COVID booster shot had fallen to 31%—too low to have been approved by the Food and Drug Administration. Though most American adults had gotten COVID vaccines, there were more than a million new COVID cases a day in January 2022. Most COVID fatalities were occurring among the fully vaxxed. Studies showed that people who received multiple boosters were actually more likely to be hit by COVID infections.
So obviously, the Biden administration had no choice but to demonize any and all COVID critics. A confidential 2022 Department of Homeland Security report detailed pending crackdowns on “inaccurate” information on “the efficacy of COVID-19 vaccines,” among other targets. A few months earlier, Jen Easterly, the chief of the Cybersecurity and Infrastructure Security Agency, declared, “We live in a world where people talk about alternative facts, post-truth, which I think is really, really dangerous if people get to pick their own facts.” Plenty of Biden administration officials considered it “really dangerous” to permit people to assert that COVID vaccines were failing.
The National Counterterrorism Center report noted, “The availability of a vaccine for all school-age children might spur conspiracy theories and perceptions that schools will vaccinate children against parents’ will.” Like the same way that some states and many school systems have sought to enable children to change their gender without their parents’ knowledge or consent?
The report also warned that “new COVID-19 mitigation measures—particularly mandates or endorsements of vaccines for children—will probably spur plotting against the government.” The FDA knew that COVID vaccines sharply increased the risk of myocarditis—an inflamed heart—in young males but the Biden White House browbeat the agency into fully approving the COVID vaccine anyhow. New York Governor Kathy Hochul sought unsuccessfully to mandate vaccines for all schoolkids in the Empire State even though her State Department of Health reported in May 2022 that the Pfizer vaccine was only 12% effective for children during the Omicron surge. The Biden administration included COVID vaccines in the semi-mandatory regimen for young children despite the vaccine’s failure and perils.
The vilification of COVID doubts propelled the Biden crackdown on uppity parents. As governments shut down schools and issued mask mandates in failed responses to COVID, parents raised hell at school board meetings. The National School Board Association denounced such criticism as “a form of domestic terrorism” and urged Team Biden to deploy the FBI and the Patriot Act against protesting parents (an initial draft of the letter called for sending in the National Guard to protect school boards).
On October 4, 2021, Attorney General Merrick Garland announced that the FBI would speedily “convene meetings” in every state aimed at “addressing threats against school administrators, board members, teachers, and staff.” The Justice Department announced that its National Security Division would help determine “how federal enforcement tools can be used” to prosecute angry parents. The Biden administration effectively announced plans to drop legal nuclear bombs on school board critics. An FBI whistleblower revealed that FBI counterterrorism tools were being used to target angry parents. FBI agents across the nation began interrogating parents whose names were reported on a “tip line” set up for people to phone in accusations against anyone who complained about school closures, mask mandates, or other issues.
Portraying doubts on COVID policy as a warning sign of domestic violent extremism unleashed the FBI to target anybody who howled against mandatory injections or the near-total destruction of their freedom of movement. That December 13, 2021 National Counterterrorism Center report may be only the tip of the iceberg of federal mischief. We may soon learn of far more direct machinations to vilify, undercut, or other stifle COVID critics.
Top FDA official admits she refused the Covid-19 vaccine while pregnant
A senior regulator’s admission reveals uncomfortable truths about silence, ethics and trust inside the FDA
By Maryanne Demasi, PhD | May 22, 2025
One of the most powerful figures at the US Food and Drug Administration (FDA) has admitted she refused the Covid-19 mRNA vaccine while pregnant—even as her agency promoted it as “safe and effective” for all pregnant women.
Dr Sara Brenner’s explosive disclosure, made on 15 May 2025 at the MAHA Institute Round Table in Washington DC, is as revealing as it is troubling.
A preventive medicine physician, Brenner has worked at the FDA since 2019. As the FDA’s Principal Deputy Commissioner—and briefly its Acting Commissioner—Brenner was at the centre of decision-making.

Dr Sara Brenner on 15 May 2025 at the MAHA Institute
Prior to that she was Chief Medical Officer for diagnostics and was detailed to the White House to support the Biden administration’s Covid-19 response. She didn’t just participate in the pandemic response, she helped shape it from within.
“Knowing what I knew—not only about nanotechnology, about medicine, about the medical countermeasures—but also having a very strong and firm grounding in bioethics… there were many things that were not right,” she told the audience.
That someone with her seniority and access to internal data privately rejected the vaccine, while her agency promoted it to millions of pregnant women, presents a profound ethical dilemma.
Brenner’s concerns about mRNA safety
Brenner explained that her decision was driven by a lack of safety data, particularly around the biodistribution of the vaccine’s lipid nanoparticles (LNPs)—the tiny fat particles used to deliver the mRNA into cells.
“It was unknown at the time what the biodistribution patterns of those products were… That was my primary concern, and that exposure I was very concerned about,” said Brenner.
She had reason to be cautious.
As a nanomedicine expert who built an MD/PhD program in the field, Brenner had spent years researching the “biodistribution, excretion, metabolism and toxicities associated with engineered nanoparticles.”
“Materials that don’t exist in nature—there’s a lot of unknowns,” said Brenner.
She warned that unintended toxic effects—especially in vulnerable populations like pregnant women—could not be ignored.
“Regardless of the medical product or the intervention, there’s always going to be the need to evaluate both the intended outcomes… and the unintended consequences,” she cautioned.
Warnings ignored
Brenner’s concerns echoed those raised in 2021 by Canadian immunologist Dr Byram Bridle, who first exposed internal documents from Japan’s regulatory agency showing that LNPs didn’t remain at the injection site, but travelled throughout the body and accumulated in organs including the ovaries, liver, spleen and bone marrow.
At the time, Bridle’s warnings were aggressively dismissed. His reputation took a hit, and he faced institutional censure from the University of Guelph, where he was a professor, for speaking out against vaccine mandates.

Dr Byram Bridle, Canadian immunologist. Photo credit: Kenneth Armstrong
Now, Brenner’s comments confirm that these concerns were not only valid—they were quietly shared at the highest levels of the FDA.
During the event, Brenner also revealed that her worries extended to breastfeeding and potential exposure to her child after birth.
A 2022 study published in JAMA Pediatrics detected vaccine-derived mRNA in the breast milk of vaccinated mothers for at least 48 hours—the very scenario Brenner had feared.
Yet the FDA made little effort to publicly investigate or address the findings, dismissing them with the vague reassurance that there was “no evidence of harm.”
No mandate for Brenner?
It’s unclear how Brenner managed to avoid the vaccine mandate that applied to all federal employees at the time. She didn’t say. Perhaps she received a religious or medical exemption—but she left that part out.
What she did reveal was that she had concerns—deep enough not to take the vaccine during her pregnancy. Yet she said nothing publicly, while her agency told millions of other women it was safe.
For many, that silence is hard to accept and it has left many asking why she didn’t warn other women about a product with ‘zero’ clinical safety data in pregnancy.
No one but Brenner knows the full story. But the ethical contradiction is hard to ignore.
Silence inside the castle
Brenner acknowledged the immense pressure inside the FDA to stick to the official narrative.
“They don’t let you get very far out of the castle at FDA with your talking points,” she admitted nervously.
She described the period as a “dark night of the soul” for many civil servants, a time when even “very obvious things” took bravery to say.
She eventually found support through a group called Feds for Medical Freedom—federal workers advocating for informed consent, bodily autonomy, and pushing back against government overreach.
A culture change?
Today, under a new administration, Brenner says the culture inside the FDA is shifting. She praised Commissioner Dr Marty Makary and said transparency is finally becoming a priority.
“We’re moving very quickly to make it such that there will be more transparency… so that people can see and evaluate for themselves what the truths are.”
But Brenner’s remarks won’t undo what has already happened—especially to those who were vaccine injured or whose pregnancies were affected.
What her comments do offer is a rare glimpse into the internal dynamics of a government institution that issued sweeping public assurances while failing to acknowledge its own uncertainty.
“There was no acknowledgement of what was unknown. There were only statements and assertions that were really more like beliefs,” Brenner said of the FDA’s messaging during the pandemic.
That may be her most important admission.
This is more than a story about one woman’s personal decision. It is a story about institutional culture, regulatory failure, and the consequences of silence.
Those who spoke up were punished. Those who stayed silent kept their jobs and reputations. And those who were forced to comply were often left to deal with the collateral damage.
When asked whether she believed she had made the right decision in refusing the Covid-19 vaccine, Brenner replied simply, “I believe so.”
Now that she has spoken, the question remains — who else knew, and said nothing?
FERTILITY FALLOUT: MRNA VACCINES LINKED TO OVARIAN DAMAGE
The HighWire with Del Bigtree | May 15, 2025
Following last week’s spotlight on a preprint showing lower conception rates in vaccinated women, a new peer-reviewed rat study shows a 60% drop in ovarian egg reserves after mRNA vaccination. With FDA meetings looming, Del and Jefferey raise urgent questions about long-term reproductive risks, and why similar research still isn’t being done in women.











